Reversible cerebral vasoconstriction syndrome: literature review.
Autor: | Ribas MZ; Federal University of Paraná (UFPR), Curitiba, Paraná Brazil., Paticcié GF; Faculty of Medicine, Federal University of Juiz de Fora, Juiz de Fora, MG Brazil., de Medeiros SDP; Facisa University Center, UNIFACISA, Campina Grande, PB Brazil., de Oliveira Veras A; Clinical Hospital of the Faculty of Medicine of Ribeirão Preto - USP, Ribeirão Prêto, SP Brazil., Noleto FM; Faculty of Medicine, Christus University Center, UNICHRISTUS, Fortaleza, CE Brazil., Dos Santos JCC; Neurosciences Laboratory, Department of Neurology and Neurosurgery, Federal University of São Paulo, Sena Madureira, 1500, Vila Clementino (SP), São Paulo, SP 04021-001 Brazil. |
---|---|
Jazyk: | angličtina |
Zdroj: | The Egyptian journal of neurology, psychiatry and neurosurgery [Egypt J Neurol Psychiatr Neurosurg] 2023; Vol. 59 (1), pp. 5. Date of Electronic Publication: 2023 Jan 11. |
DOI: | 10.1186/s41983-023-00607-9 |
Abstrakt: | Reversible Cerebral Vasoconstriction Syndrome (RCVS) is a neurovascular condition characterized by a severe sudden-onset headache that may be associated with focal neurological deficits. On imaging, the suggestive finding corresponds to multifocal vasoconstriction of the cerebral arteries, with a spontaneous resolution of approximately 12 weeks. The identification of precipitating factors and diagnosis must be carried out early, so that adequate management is established and the patient has a good prognosis, given the risk of secondary complications and residual neurological deficits. This study consists of a literature review based on the analysis of articles published between 2017 and 2022 in PubMed, SciELO, and ScienceDirect on RCVS, intending to understand the clinical and radiological characteristics, diagnosis, treatment, and prognosis of patients with RCVS. The pathophysiology, drug management, and prognosis still lack solid evidence; therefore, further studies on RCVS are needed to expand medical knowledge and avoid underdiagnosis and inadequate treatment of this important condition. Competing Interests: Competing interestsThe authors declare that they have no competing interests. (© The Author(s) 2023.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |